tamsulosin

(redirected from Tamsulosin hydrochloride)
Also found in: Dictionary.

tamsulosin

 [tam-soo´lo-sin]
an alpha-adrenergic blocking agent specific for receptors in the prostate; used as the hydrochloride salt in treatment of benign prostatic hyperplasia, administered orally.

tamsulosin

/tam·su·lo·sin/ (tam-soo´lo-sin) an α specific for the receptors in the prostate; used as the hydrochloride salt in the treatment of benign prostatic hyperplasia.

tamsulosin

a selective antiadrenergic agent.
indications This drug is used to treat symptoms of benign prostatic hyperplasia.
contraindication Known hypersensitivity to this drug prohibits its use.
adverse effects Adverse effects of this drug include asthenia, insomnia, chest pain, amblyopia, floppy iris syndrome, nausea, diarrhea, dysgeusia, decreased libido, abnormal ejaculation, back pain, rhinitis, pharyngitis, and cough. Common side effects include dizziness and headache.

tamsulosin

A selective alpha-adrenergic smooth muscle relaxing drug that is used to relieve the symptoms of enlargement of the PROSTATE GLAND. A brand name is Flomax MR.
References in periodicals archive ?
Astellas Pharma claims that it holds a formulation patent of tamsulosin hydrochloride that expires in March 2006.
Watson's dutasteride and tamsulosin hydrochloride capsules are a generic version of GlaxoSmithKline's (LON: GSK) JALYN.
The company said that these tamsulosin hydrochloride capsules, 0.
The settlement of the litigation provided the Company with the opportunity to launch its generic tamsulosin hydrochloride product on March 2, 2010, prior to the expiration of pediatric exclusivity.
The settlement of the litigation provides Impax with the opportunity to launch a generic tamsulosin hydrochloride product on March 2, 2010, prior to the expiration of pediatric exclusivity.
Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Tamsulosin Hydrochloride Capsules, 0.
Flomax(R), Pradif(R), Alna(R) are trademarks of tamsulosin hydrochloride, marketed by Boehringer Ingelheim under a license of Yamanouchi Pharmaceutical Co.
Tenders are invited for Each Tab Contains Tamsulosin Hydrochloride 0.